Boragen Inc., established in 2017 in Research Triangle Park, is focused on leveraging the unique chemical properties of boron to develop novel synthetic chemistry platforms to produce next-generation fungicides that support more sustainable farming methods. The company's lead compound decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/02/17 | $10,000,000 | Series A |
Alexandria Venture Investments ARCH Venture Partners Bayer Bill & Melinda Gates Foundation Elanco Animal Health Flagship Pioneering Hatteras Venture Partners Mountain Group Capital Pappas Capital Syngenta Ventures | undisclosed |
